Protein Adsorption to In-Line Filters of Intravenous Administration Sets.

Ensuring compatibility of administered therapeutic proteins with intravenous administration sets is an important regulatory requirement. A low-dose recovery during administration of low protein concentrations is among the commonly observed incompatibilities, and it is mainly due to adsorption to in-line filters. To better understand this phenomenon, we studied the adsorption of 4 different therapeutic proteins (2 IgG1s, 1 IgG4, and 1 Fc fusion protein) diluted to 0.01 mg/mL in 5% glucose (B. Braun EcoFlac; B. Braun Melsungen AG, Melsungen, Germany) or 0.9% sodium chloride (NaCl; Freeflex; Fresenius Kabi, Friedberg, Germany) solutions to 8 in-line filters (5 positively charged and 3 neutral filters made of different polymers and by different suppliers). The results show certain patterns of protein adsorption, which depend to a large extent on the dilution solution and filter material, and to a much lower extent on the proteins' biophysical properties. Investigation of the filter membranes' zeta potential showed a correlation between the observed adsorption pattern in 5% glucose solution and the filter's surface charge, with higher protein adsorption for the strongly negatively charged membranes. In 0.9% NaCl solution, the surface charges are masked, leading to different adsorption patterns. These results contribute to the general understanding of the protein adsorption to IV infusion filters and allow the design of more efficient compatibility studies.

[1]  P. Deluca,et al.  Effect of inline filtration on the potency of low-dose drugs. , 1980, American journal of hospital pharmacy.

[2]  K. Bethune,et al.  Use of filters during the preparation and administration of parenteral nutrition: position paper and guidelines prepared by a British pharmaceutical nutrition group working party. , 2001, Nutrition.

[3]  C. Leopold,et al.  Drug retention by inline filters--effect of positively charged polyethersulfone filter membranes on drug solutions with low concentration. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[4]  Steffen Hartmann,et al.  Best Practices in Assessment of Developability of Biopharmaceutical Candidates , 2015 .

[5]  W. Xu,et al.  Developability studies before initiation of process development , 2013, mAbs.

[6]  G. Winter,et al.  Particle contamination of parenteralia and in-line filtration of proteinaceous drugs. , 2015, International journal of pharmaceutics.

[7]  Renbi Bai,et al.  Achieving highly effective non-biofouling performance for polypropylene membranes modified by UV-induced surface graft polymerization of two oppositely charged monomers. , 2010, The journal of physical chemistry. B.

[8]  R. Merritt,et al.  In Vitro Study of Inline Filtration of Medications Commonly Administered to Pediatric Cancer Patients , 1983 .

[9]  Sandeep Yadav,et al.  Compatibility and stability of pertuzumab and trastuzumab admixtures in i.v. infusion bags for coadministration. , 2013, Journal of pharmaceutical sciences.

[10]  C Russell Middaugh,et al.  Compatibility, physical stability, and characterization of an IgG4 monoclonal antibody after dilution into different intravenous administration bags. , 2012, Journal of pharmaceutical sciences.

[11]  C. Pace,et al.  A summary of the measured pK values of the ionizable groups in folded proteins , 2008, Protein science : a publication of the Protein Society.

[12]  Alavattam Sreedhara,et al.  Stability of IgG1 monoclonal antibodies in intravenous infusion bags under clinical in-use conditions. , 2012, Journal of pharmaceutical sciences.

[13]  Sorina Morar-Mitrica,et al.  Development of a stable low-dose aglycosylated antibody formulation to minimize protein loss during intravenous administration , 2015, mAbs.

[14]  Thomas Jack,et al.  In-line filtration reduces severe complications and length of stay on pediatric intensive care unit: a prospective, randomized, controlled trial , 2012, Intensive Care Medicine.

[15]  R. Bernstein,et al.  Bacterial attachment to RO membranes surface-modified by concentration-polarization-enhanced graft polymerization. , 2011, Environmental science & technology.

[16]  D. Kalonia,et al.  Determination of second virial coefficient of proteins using a dual-detector cell for simultaneous measurement of scattered light intensity and concentration in SEC-HPLC. , 2004, Biophysical journal.

[17]  Ralf Zimmermann,et al.  Hydroxide and hydronium ion adsorption — A survey , 2010 .

[18]  Rune A. Hartvig,et al.  The importance of interfaces in protein drug delivery – why is protein adsorption of interest in pharmaceutical formulations? , 2011, Expert opinion on drug delivery.

[19]  K. Taylor,et al.  Adsorption of insulin onto infusion sets used in adult intensive care unit and neonatal care settings. , 2008, Diabetes research and clinical practice.

[20]  Stefan Seeger,et al.  Understanding protein adsorption phenomena at solid surfaces. , 2011, Advances in colloid and interface science.

[21]  Y. Kataoka,et al.  Evaluation of the in‐line filters for the intravenous infusion of amphotericin B fluid , 1999, Journal of clinical pharmacy and therapeutics.

[22]  H. Kettenberger,et al.  Developability assessment during the selection of novel therapeutic antibodies. , 2015, Journal of pharmaceutical sciences.

[23]  H. Jacobasch,et al.  Characterisation of pure or coated metal surfaces with streaming potential measurements , 1997 .